APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ketorolac Tromethamine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Ketorolac Tromethamine Market Analysis and Forecast 2026-2032

22 December 2025195 pages

Choose your research edition.

Industry ResearchKetorolac Tromethamine Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Ketorolac Tromethamine Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Ketorolac Tromethamine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ketorolac Tromethamine Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Ketorolac Tromethamine Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Ketorolac Tromethamine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Ketorolac Tromethamine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Ketorolac Tromethamine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Ketorolac Tromethamine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Ketorolac Tromethamine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Ketorolac Tromethamine include Teva, Sun Pharmaceutical, Sandoz, Mylan, Pfizer, Sagent Pharmaceuticals, Omeros Corporation, Gland Pharma Limited and Egalet US Inc., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Ketorolac Tromethamine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Ketorolac Tromethamine, also provides the sales of main regions and countries. Of the upcoming market potential for Ketorolac Tromethamine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Ketorolac Tromethamine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Ketorolac Tromethamine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Ketorolac Tromethamine sales, projected growth trends, production technology, application and end-user industry.

Ketorolac Tromethamine Segment by Company

Teva

Sun Pharmaceutical

Sandoz

Mylan

Pfizer

Sagent Pharmaceuticals

Omeros Corporation

Gland Pharma Limited

Egalet US Inc.

Dr. Reddy’s Laboratories

Aurobindo Pharma

Apotex

Amphastar Pharmaceuticals

Allergan

Akorn

Ketorolac Tromethamine Segment by Type

Nasal

Oral tablet

Ophthalmic

Injection

Ketorolac Tromethamine Segment by Application

Hospital

Clinic

Others

Ketorolac Tromethamine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ketorolac Tromethamine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ketorolac Tromethamine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ketorolac Tromethamine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Ketorolac Tromethamine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Ketorolac Tromethamine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Ketorolac Tromethamine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Ketorolac Tromethamine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Nasal Major Manufacturers Table 3. Oral tablet Major Manufacturers Table 4. Ophthalmic Major Manufacturers Table 5. Injection Major Manufacturers Table 6. Global Ketorolac Tromethamine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospital Major Manufacturers Table 8. Clinic Major Manufacturers Table 9. Others Major Manufacturers Table 10. Ketorolac Tromethamine Industry Trends Table 11. Ketorolac Tromethamine Industry Drivers Table 12. Ketorolac Tromethamine Industry Opportunities and Challenges Table 13. Ketorolac Tromethamine Industry Restraints Table 14. Global Ketorolac Tromethamine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Ketorolac Tromethamine Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Ketorolac Tromethamine Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Ketorolac Tromethamine Revenue Market Share by Region (2021-2026) Table 18. Global Ketorolac Tromethamine Revenue Market Share by Region (2027-2032) Table 19. Global Ketorolac Tromethamine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 20. Global Ketorolac Tromethamine Sales by Region (2021-2026) & (k units) Table 21. Global Ketorolac Tromethamine Sales by Region (2027-2032) & (k units) Table 22. Global Ketorolac Tromethamine Sales Market Share by Region (2021-2026) Table 23. Global Ketorolac Tromethamine Sales Market Share by Region (2027-2032) Table 24. Global Ketorolac Tromethamine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Ketorolac Tromethamine Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Ketorolac Tromethamine Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Ketorolac Tromethamine Sales Market Share by Manufacturers (2021-2026) Table 28. Global Ketorolac Tromethamine Sales Price (US$/unit) of Manufacturers (2021-2026) Table 29. Global Ketorolac Tromethamine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Ketorolac Tromethamine Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Ketorolac Tromethamine Manufacturers, Product Type & Application Table 32. Global Ketorolac Tromethamine Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Ketorolac Tromethamine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Ketorolac Tromethamine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Ketorolac Tromethamine Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Ketorolac Tromethamine Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Ketorolac Tromethamine Revenue Market Share by Type (2021-2026) Table 39. Global Ketorolac Tromethamine Revenue Market Share by Type (2027-2032) Table 40. Global Ketorolac Tromethamine Sales by Type 2021 VS 2025 VS 2032 (k units) Table 41. Global Ketorolac Tromethamine Sales by Type (2021-2026) & (k units) Table 42. Global Ketorolac Tromethamine Sales by Type (2027-2032) & (k units) Table 43. Global Ketorolac Tromethamine Sales Market Share by Type (2021-2026) Table 44. Global Ketorolac Tromethamine Sales Market Share by Type (2027-2032) Table 45. Global Ketorolac Tromethamine Price by Type (2021-2026) & (US$/unit) Table 46. Global Ketorolac Tromethamine Price by Type (2027-2032) & (US$/unit) Table 47. Global Ketorolac Tromethamine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Ketorolac Tromethamine Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Ketorolac Tromethamine Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Ketorolac Tromethamine Revenue Market Share by Application (2021-2026) Table 51. Global Ketorolac Tromethamine Revenue Market Share by Application (2027-2032) Table 52. Global Ketorolac Tromethamine Sales by Application 2021 VS 2025 VS 2032 (k units) Table 53. Global Ketorolac Tromethamine Sales by Application (2021-2026) & (k units) Table 54. Global Ketorolac Tromethamine Sales by Application (2027-2032) & (k units) Table 55. Global Ketorolac Tromethamine Sales Market Share by Application (2021-2026) Table 56. Global Ketorolac Tromethamine Sales Market Share by Application (2027-2032) Table 57. Global Ketorolac Tromethamine Price by Application (2021-2026) & (US$/unit) Table 58. Global Ketorolac Tromethamine Price by Application (2027-2032) & (US$/unit) Table 59. Teva Company Information Table 60. Teva Business Overview Table 61. Teva Ketorolac Tromethamine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 62. Teva Ketorolac Tromethamine Product Portfolio Table 63. Teva Recent Development Table 64. Sun Pharmaceutical Company Information Table 65. Sun Pharmaceutical Business Overview Table 66. Sun Pharmaceutical Ketorolac Tromethamine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Sun Pharmaceutical Ketorolac Tromethamine Product Portfolio Table 68. Sun Pharmaceutical Recent Development Table 69. Sandoz Company Information Table 70. Sandoz Business Overview Table 71. Sandoz Ketorolac Tromethamine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Sandoz Ketorolac Tromethamine Product Portfolio Table 73. Sandoz Recent Development Table 74. Mylan Company Information Table 75. Mylan Business Overview Table 76. Mylan Ketorolac Tromethamine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Mylan Ketorolac Tromethamine Product Portfolio Table 78. Mylan Recent Development Table 79. Pfizer Company Information Table 80. Pfizer Business Overview Table 81. Pfizer Ketorolac Tromethamine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Pfizer Ketorolac Tromethamine Product Portfolio Table 83. Pfizer Recent Development Table 84. Sagent Pharmaceuticals Company Information Table 85. Sagent Pharmaceuticals Business Overview Table 86. Sagent Pharmaceuticals Ketorolac Tromethamine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Sagent Pharmaceuticals Ketorolac Tromethamine Product Portfolio Table 88. Sagent Pharmaceuticals Recent Development Table 89. Omeros Corporation Company Information Table 90. Omeros Corporation Business Overview Table 91. Omeros Corporation Ketorolac Tromethamine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Omeros Corporation Ketorolac Tromethamine Product Portfolio Table 93. Omeros Corporation Recent Development Table 94. Gland Pharma Limited Company Information Table 95. Gland Pharma Limited Business Overview Table 96. Gland Pharma Limited Ketorolac Tromethamine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Gland Pharma Limited Ketorolac Tromethamine Product Portfolio Table 98. Gland Pharma Limited Recent Development Table 99. Egalet US Inc. Company Information Table 100. Egalet US Inc. Business Overview Table 101. Egalet US Inc. Ketorolac Tromethamine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Egalet US Inc. Ketorolac Tromethamine Product Portfolio Table 103. Egalet US Inc. Recent Development Table 104. Dr. Reddy’s Laboratories Company Information Table 105. Dr. Reddy’s Laboratories Business Overview Table 106. Dr. Reddy’s Laboratories Ketorolac Tromethamine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Dr. Reddy’s Laboratories Ketorolac Tromethamine Product Portfolio Table 108. Dr. Reddy’s Laboratories Recent Development Table 109. Aurobindo Pharma Company Information Table 110. Aurobindo Pharma Business Overview Table 111. Aurobindo Pharma Ketorolac Tromethamine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Aurobindo Pharma Ketorolac Tromethamine Product Portfolio Table 113. Aurobindo Pharma Recent Development Table 114. Apotex Company Information Table 115. Apotex Business Overview Table 116. Apotex Ketorolac Tromethamine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. Apotex Ketorolac Tromethamine Product Portfolio Table 118. Apotex Recent Development Table 119. Amphastar Pharmaceuticals Company Information Table 120. Amphastar Pharmaceuticals Business Overview Table 121. Amphastar Pharmaceuticals Ketorolac Tromethamine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 122. Amphastar Pharmaceuticals Ketorolac Tromethamine Product Portfolio Table 123. Amphastar Pharmaceuticals Recent Development Table 124. Allergan Company Information Table 125. Allergan Business Overview Table 126. Allergan Ketorolac Tromethamine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 127. Allergan Ketorolac Tromethamine Product Portfolio Table 128. Allergan Recent Development Table 129. Akorn Company Information Table 130. Akorn Business Overview Table 131. Akorn Ketorolac Tromethamine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 132. Akorn Ketorolac Tromethamine Product Portfolio Table 133. Akorn Recent Development Table 134. North America Ketorolac Tromethamine Revenue by Type (2021-2026) & (US$ Million) Table 135. North America Ketorolac Tromethamine Revenue by Type (2027-2032) & (US$ Million) Table 136. North America Ketorolac Tromethamine Sales by Type (2021-2026) & (k units) Table 137. North America Ketorolac Tromethamine Sales by Type (2027-2032) & (k units) Table 138. North America Ketorolac Tromethamine Sales Price by Type (2021-2026) & (US$/unit) Table 139. North America Ketorolac Tromethamine Sales Price by Type (2027-2032) & (US$/unit) Table 140. North America Ketorolac Tromethamine Revenue by Application (2021-2026) & (US$ Million) Table 141. North America Ketorolac Tromethamine Revenue by Application (2027-2032) & (US$ Million) Table 142. North America Ketorolac Tromethamine Sales by Application (2021-2026) & (k units) Table 143. North America Ketorolac Tromethamine Sales by Application (2027-2032) & (k units) Table 144. North America Ketorolac Tromethamine Sales Price by Application (2021-2026) & (US$/unit) Table 145. North America Ketorolac Tromethamine Sales Price by Application (2027-2032) & (US$/unit) Table 146. North America Ketorolac Tromethamine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. North America Ketorolac Tromethamine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 148. North America Ketorolac Tromethamine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 149. North America Ketorolac Tromethamine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 150. North America Ketorolac Tromethamine Sales by Country (2021-2026) & (k units) Table 151. North America Ketorolac Tromethamine Sales by Country (2027-2032) & (k units) Table 152. North America Ketorolac Tromethamine Sales Price by Country (2021-2026) & (US$/unit) Table 153. North America Ketorolac Tromethamine Sales Price by Country (2027-2032) & (US$/unit) Table 154. United States Ketorolac Tromethamine Revenue (2021-2032) & (US$ Million) Table 155. Canada Ketorolac Tromethamine Revenue (2021-2032) & (US$ Million) Table 156. Mexico Ketorolac Tromethamine Revenue (2021-2032) & (US$ Million) Table 157. Europe Ketorolac Tromethamine Revenue by Type (2021-2026) & (US$ Million) Table 158. Europe Ketorolac Tromethamine Revenue by Type (2027-2032) & (US$ Million) Table 159. Europe Ketorolac Tromethamine Sales by Type (2021-2026) & (k units) Table 160. Europe Ketorolac Tromethamine Sales by Type (2027-2032) & (k units) Table 161. Europe Ketorolac Tromethamine Sales Price by Type (2021-2026) & (US$/unit) Table 162. Europe Ketorolac Tromethamine Sales Price by Type (2027-2032) & (US$/unit) Table 163. Europe Ketorolac Tromethamine Revenue by Application (2021-2026) & (US$ Million) Table 164. Europe Ketorolac Tromethamine Revenue by Application (2027-2032) & (US$ Million) Table 165. Europe Ketorolac Tromethamine Sales by Application (2021-2026) & (k units) Table 166. Europe Ketorolac Tromethamine Sales by Application (2027-2032) & (k units) Table 167. Europe Ketorolac Tromethamine Sales Price by Application (2021-2026) & (US$/unit) Table 168. Europe Ketorolac Tromethamine Sales Price by Application (2027-2032) & (US$/unit) Table 169. Europe Ketorolac Tromethamine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. Europe Ketorolac Tromethamine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 171. Europe Ketorolac Tromethamine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 172. Europe Ketorolac Tromethamine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 173. Europe Ketorolac Tromethamine Sales by Country (2021-2026) & (k units) Table 174. Europe Ketorolac Tromethamine Sales by Country (2027-2032) & (k units) Table 175. Europe Ketorolac Tromethamine Sales Price by Country (2021-2026) & (US$/unit) Table 176. Europe Ketorolac Tromethamine Sales Price by Country (2027-2032) & (US$/unit) Table 177. Germany Ketorolac Tromethamine Revenue (2021-2032) & (US$ Million) Table 178. France Ketorolac Tromethamine Revenue (2021-2032) & (US$ Million) Table 179. U.K. Ketorolac Tromethamine Revenue (2021-2032) & (US$ Million) Table 180. Italy Ketorolac Tromethamine Revenue (2021-2032) & (US$ Million) Table 181. Russia Ketorolac Tromethamine Revenue (2021-2032) & (US$ Million) Table 182. Spain Ketorolac Tromethamine Revenue (2021-2032) & (US$ Million) Table 183. Netherlands Ketorolac Tromethamine Revenue (2021-2032) & (US$ Million) Table 184. Switzerland Ketorolac Tromethamine Revenue (2021-2032) & (US$ Million) Table 185. Sweden Ketorolac Tromethamine Revenue (2021-2032) & (US$ Million) Table 186. Poland Ketorolac Tromethamine Revenue (2021-2032) & (US$ Million) Table 187. China Ketorolac Tromethamine Revenue by Type (2021-2026) & (US$ Million) Table 188. China Ketorolac Tromethamine Revenue by Type (2027-2032) & (US$ Million) Table 189. China Ketorolac Tromethamine Sales by Type (2021-2026) & (k units) Table 190. China Ketorolac Tromethamine Sales by Type (2027-2032) & (k units) Table 191. China Ketorolac Tromethamine Sales Price by Type (2021-2026) & (US$/unit) Table 192. China Ketorolac Tromethamine Sales Price by Type (2027-2032) & (US$/unit) Table 193. China Ketorolac Tromethamine Revenue by Application (2021-2026) & (US$ Million) Table 194. China Ketorolac Tromethamine Revenue by Application (2027-2032) & (US$ Million) Table 195. China Ketorolac Tromethamine Sales by Application (2021-2026) & (k units) Table 196. China Ketorolac Tromethamine Sales by Application (2027-2032) & (k units) Table 197. China Ketorolac Tromethamine Sales Price by Application (2021-2026) & (US$/unit) Table 198. China Ketorolac Tromethamine Sales Price by Application (2027-2032) & (US$/unit) Table 199. Asia Ketorolac Tromethamine Revenue by Type (2021-2026) & (US$ Million) Table 200. Asia Ketorolac Tromethamine Revenue by Type (2027-2032) & (US$ Million) Table 201. Asia Ketorolac Tromethamine Sales by Type (2021-2026) & (k units) Table 202. Asia Ketorolac Tromethamine Sales by Type (2027-2032) & (k units) Table 203. Asia Ketorolac Tromethamine Sales Price by Type (2021-2026) & (US$/unit) Table 204. Asia Ketorolac Tromethamine Sales Price by Type (2027-2032) & (US$/unit) Table 205. Asia Ketorolac Tromethamine Revenue by Application (2021-2026) & (US$ Million) Table 206. Asia Ketorolac Tromethamine Revenue by Application (2027-2032) & (US$ Million) Table 207. Asia Ketorolac Tromethamine Sales by Application (2021-2026) & (k units) Table 208. Asia Ketorolac Tromethamine Sales by Application (2027-2032) & (k units) Table 209. Asia Ketorolac Tromethamine Sales Price by Application (2021-2026) & (US$/unit) Table 210. Asia Ketorolac Tromethamine Sales Price by Application (2027-2032) & (US$/unit) Table 211. Asia Ketorolac Tromethamine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 212. Asia Ketorolac Tromethamine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 213. Asia Ketorolac Tromethamine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 214. Asia Ketorolac Tromethamine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 215. Asia Ketorolac Tromethamine Sales by Country (2021-2026) & (k units) Table 216. Asia Ketorolac Tromethamine Sales by Country (2027-2032) & (k units) Table 217. Asia Ketorolac Tromethamine Sales Price by Country (2021-2026) & (US$/unit) Table 218. Asia Ketorolac Tromethamine Sales Price by Country (2027-2032) & (US$/unit) Table 219. Japan Ketorolac Tromethamine Revenue (2021-2032) & (US$ Million) Table 220. South Korea Ketorolac Tromethamine Revenue (2021-2032) & (US$ Million) Table 221. India Ketorolac Tromethamine Revenue (2021-2032) & (US$ Million) Table 222. Australia Ketorolac Tromethamine Revenue (2021-2032) & (US$ Million) Table 223. Taiwan Ketorolac Tromethamine Revenue (2021-2032) & (US$ Million) Table 224. Southeast Asia Ketorolac Tromethamine Revenue (2021-2032) & (US$ Million) Table 225. SAMEA Ketorolac Tromethamine Revenue by Type (2021-2026) & (US$ Million) Table 226. SAMEA Ketorolac Tromethamine Revenue by Type (2027-2032) & (US$ Million) Table 227. SAMEA Ketorolac Tromethamine Sales by Type (2021-2026) & (k units) Table 228. SAMEA Ketorolac Tromethamine Sales by Type (2027-2032) & (k units) Table 229. SAMEA Ketorolac Tromethamine Sales Price by Type (2021-2026) & (US$/unit) Table 230. SAMEA Ketorolac Tromethamine Sales Price by Type (2027-2032) & (US$/unit) Table 231. SAMEA Ketorolac Tromethamine Revenue by Application (2021-2026) & (US$ Million) Table 232. SAMEA Ketorolac Tromethamine Revenue by Application (2027-2032) & (US$ Million) Table 233. SAMEA Ketorolac Tromethamine Sales by Application (2021-2026) & (k units) Table 234. SAMEA Ketorolac Tromethamine Sales by Application (2027-2032) & (k units) Table 235. SAMEA Ketorolac Tromethamine Sales Price by Application (2021-2026) & (US$/unit) Table 236. SAMEA Ketorolac Tromethamine Sales Price by Application (2027-2032) & (US$/unit) Table 237. SAMEA Ketorolac Tromethamine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 238. SAMEA Ketorolac Tromethamine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 239. SAMEA Ketorolac Tromethamine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 240. SAMEA Ketorolac Tromethamine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 241. SAMEA Ketorolac Tromethamine Sales by Country (2021-2026) & (k units) Table 242. SAMEA Ketorolac Tromethamine Sales by Country (2027-2032) & (k units) Table 243. SAMEA Ketorolac Tromethamine Sales Price by Country (2021-2026) & (US$/unit) Table 244. SAMEA Ketorolac Tromethamine Sales Price by Country (2027-2032) & (US$/unit) Table 245. Brazil Ketorolac Tromethamine Revenue (2021-2032) & (US$ Million) Table 246. Argentina Ketorolac Tromethamine Revenue (2021-2032) & (US$ Million) Table 247. Chile Ketorolac Tromethamine Revenue (2021-2032) & (US$ Million) Table 248. Colombia Ketorolac Tromethamine Revenue (2021-2032) & (US$ Million) Table 249. Peru Ketorolac Tromethamine Revenue (2021-2032) & (US$ Million) Table 250. Saudi Arabia Ketorolac Tromethamine Revenue (2021-2032) & (US$ Million) Table 251. Israel Ketorolac Tromethamine Revenue (2021-2032) & (US$ Million) Table 252. UAE Ketorolac Tromethamine Revenue (2021-2032) & (US$ Million) Table 253. Turkey Ketorolac Tromethamine Revenue (2021-2032) & (US$ Million) Table 254. Iran Ketorolac Tromethamine Revenue (2021-2032) & (US$ Million) Table 255. Egypt Ketorolac Tromethamine Revenue (2021-2032) & (US$ Million) Table 256. Key Raw Materials Table 257. Raw Materials Key Suppliers Table 258. Ketorolac Tromethamine Distributors List Table 259. Ketorolac Tromethamine Customers List Table 260. Research Programs/Design for This Report Table 261. Authors List of This Report Table 262. Secondary Sources Table 263. Primary Sources List of Figures Figure 1. Ketorolac Tromethamine Image Figure 2. Global Ketorolac Tromethamine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ketorolac Tromethamine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Nasal Image Figure 5. Oral tablet Image Figure 6. Ophthalmic Image Figure 7. Injection Image Figure 8. Global Ketorolac Tromethamine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Ketorolac Tromethamine Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospital Image Figure 11. Clinic Image Figure 12. Others Image Figure 13. Global Ketorolac Tromethamine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Ketorolac Tromethamine Revenue (2021-2032) & (US$ Million) Figure 15. Global Ketorolac Tromethamine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Ketorolac Tromethamine Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Ketorolac Tromethamine Revenue Market Share by Region (2021-2032) Figure 18. Global Ketorolac Tromethamine Sales (2021-2032) & (k units) Figure 19. Global Ketorolac Tromethamine Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 20. Global Ketorolac Tromethamine Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Ketorolac Tromethamine Sales YoY (2021-2032) & (k units) Figure 22. Europe Ketorolac Tromethamine Sales YoY (2021-2032) & (k units) Figure 23. China Ketorolac Tromethamine Sales YoY (2021-2032) & (k units) Figure 24. Asia (Excluding China) Ketorolac Tromethamine Sales YoY (2021-2032) & (k units) Figure 25. South America, Middle East and Africa Ketorolac Tromethamine Sales YoY (2021-2032) & (k units) Figure 26. Global Ketorolac Tromethamine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Ketorolac Tromethamine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Ketorolac Tromethamine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Ketorolac Tromethamine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Ketorolac Tromethamine Revenue Market Share by Type (2021-2032) Figure 32. Global Ketorolac Tromethamine Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 33. Global Ketorolac Tromethamine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Ketorolac Tromethamine Sales Market Share by Type (2021-2032) Figure 35. Global Ketorolac Tromethamine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Ketorolac Tromethamine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Ketorolac Tromethamine Revenue Market Share by Application (2021-2032) Figure 38. Global Ketorolac Tromethamine Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 39. Global Ketorolac Tromethamine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Ketorolac Tromethamine Sales Market Share by Application (2021-2032) Figure 41. North America Ketorolac Tromethamine Revenue Share by Type (2021-2032) Figure 42. North America Ketorolac Tromethamine Sales Share by Type (2021-2032) Figure 43. North America Ketorolac Tromethamine Revenue Share by Application (2021-2032) Figure 44. North America Ketorolac Tromethamine Sales Share by Application (2021-2032) Figure 45. North America Ketorolac Tromethamine Revenue Share by Country (2021-2032) Figure 46. North America Ketorolac Tromethamine Sales Share by Country (2021-2032) Figure 47. Europe Ketorolac Tromethamine Revenue Share by Type (2021-2032) Figure 48. Europe Ketorolac Tromethamine Sales Share by Type (2021-2032) Figure 49. Europe Ketorolac Tromethamine Revenue Share by Application (2021-2032) Figure 50. Europe Ketorolac Tromethamine Sales Share by Application (2021-2032) Figure 51. Europe Ketorolac Tromethamine Revenue Share by Country (2021-2032) Figure 52. Europe Ketorolac Tromethamine Sales Share by Country (2021-2032) Figure 53. China Ketorolac Tromethamine Revenue Share by Type (2021-2032) Figure 54. China Ketorolac Tromethamine Sales Share by Type (2021-2032) Figure 55. China Ketorolac Tromethamine Revenue Share by Application (2021-2032) Figure 56. China Ketorolac Tromethamine Sales Share by Application (2021-2032) Figure 57. Asia Ketorolac Tromethamine Revenue Share by Type (2021-2032) Figure 58. Asia Ketorolac Tromethamine Sales Share by Type (2021-2032) Figure 59. Asia Ketorolac Tromethamine Revenue Share by Application (2021-2032) Figure 60. Asia Ketorolac Tromethamine Sales Share by Application (2021-2032) Figure 61. Asia Ketorolac Tromethamine Revenue Share by Country (2021-2032) Figure 62. Asia Ketorolac Tromethamine Sales Share by Country (2021-2032) Figure 63. SAMEA Ketorolac Tromethamine Revenue Share by Type (2021-2032) Figure 64. SAMEA Ketorolac Tromethamine Sales Share by Type (2021-2032) Figure 65. SAMEA Ketorolac Tromethamine Revenue Share by Application (2021-2032) Figure 66. SAMEA Ketorolac Tromethamine Sales Share by Application (2021-2032) Figure 67. SAMEA Ketorolac Tromethamine Revenue Share by Country (2021-2032) Figure 68. SAMEA Ketorolac Tromethamine Sales Share by Country (2021-2032) Figure 69. Ketorolac Tromethamine Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Ketorolac Tromethamine Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Nasal
  • Oral tablet
  • Ophthalmic
  • Injection
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Teva
  • Sun Pharmaceutical
  • Sandoz
  • Mylan
  • Pfizer
  • Sagent Pharmaceuticals
  • Omeros Corporation
  • Gland Pharma Limited
  • Egalet US Inc.
  • Dr. Reddy’s Laboratories
  • Aurobindo Pharma
  • Apotex
  • Amphastar Pharmaceuticals
  • Allergan
  • Akorn

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Ketorolac Tromethamine Market by Type
  3. 1.2.1 Global Ketorolac Tromethamine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Nasal
  5. 1.2.3 Oral tablet
  6. 1.2.4 Ophthalmic
  7. 1.2.5 Injection
  8. 1.3 Ketorolac Tromethamine Market by Application
  9. 1.3.1 Global Ketorolac Tromethamine Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Clinic
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Ketorolac Tromethamine Market Dynamics
  1. 2.1 Ketorolac Tromethamine Industry Trends
  2. 2.2 Ketorolac Tromethamine Industry Drivers
  3. 2.3 Ketorolac Tromethamine Industry Opportunities and Challenges
  4. 2.4 Ketorolac Tromethamine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Ketorolac Tromethamine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Ketorolac Tromethamine Revenue by Region
  3. 3.2.1 Global Ketorolac Tromethamine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Ketorolac Tromethamine Revenue by Region (2021-2026)
  5. 3.2.3 Global Ketorolac Tromethamine Revenue by Region (2027-2032)
  6. 3.2.4 Global Ketorolac Tromethamine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Ketorolac Tromethamine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Ketorolac Tromethamine Sales by Region
  9. 3.4.1 Global Ketorolac Tromethamine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Ketorolac Tromethamine Sales by Region (2021-2026)
  11. 3.4.3 Global Ketorolac Tromethamine Sales by Region (2027-2032)
  12. 3.4.4 Global Ketorolac Tromethamine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Ketorolac Tromethamine Revenue by Manufacturers
  2. 4.1.1 Global Ketorolac Tromethamine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Ketorolac Tromethamine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Ketorolac Tromethamine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Ketorolac Tromethamine Sales by Manufacturers
  6. 4.2.1 Global Ketorolac Tromethamine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Ketorolac Tromethamine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Ketorolac Tromethamine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Ketorolac Tromethamine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Ketorolac Tromethamine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Ketorolac Tromethamine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Ketorolac Tromethamine Manufacturers, Product Type & Application
  13. 4.7 Global Ketorolac Tromethamine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Ketorolac Tromethamine Market CR5 and HHI
  16. 4.8.2 2025 Ketorolac Tromethamine Tier 1, Tier 2, and Tier 3
5 Ketorolac Tromethamine Market by Type
  1. 5.1 Global Ketorolac Tromethamine Revenue by Type
  2. 5.1.1 Global Ketorolac Tromethamine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Ketorolac Tromethamine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Ketorolac Tromethamine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Ketorolac Tromethamine Sales by Type
  6. 5.2.1 Global Ketorolac Tromethamine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Ketorolac Tromethamine Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Ketorolac Tromethamine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Ketorolac Tromethamine Price by Type
6 Ketorolac Tromethamine Market by Application
  1. 6.1 Global Ketorolac Tromethamine Revenue by Application
  2. 6.1.1 Global Ketorolac Tromethamine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Ketorolac Tromethamine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Ketorolac Tromethamine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Ketorolac Tromethamine Sales by Application
  6. 6.2.1 Global Ketorolac Tromethamine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Ketorolac Tromethamine Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Ketorolac Tromethamine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Ketorolac Tromethamine Price by Application
7 Company Profiles
  1. 7.1 Teva
  2. 7.1.1 Teva Company Information
  3. 7.1.2 Teva Business Overview
  4. 7.1.3 Teva Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Teva Ketorolac Tromethamine Product Portfolio
  6. 7.1.5 Teva Recent Developments
  7. 7.2 Sun Pharmaceutical
  8. 7.2.1 Sun Pharmaceutical Company Information
  9. 7.2.2 Sun Pharmaceutical Business Overview
  10. 7.2.3 Sun Pharmaceutical Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sun Pharmaceutical Ketorolac Tromethamine Product Portfolio
  12. 7.2.5 Sun Pharmaceutical Recent Developments
  13. 7.3 Sandoz
  14. 7.3.1 Sandoz Company Information
  15. 7.3.2 Sandoz Business Overview
  16. 7.3.3 Sandoz Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sandoz Ketorolac Tromethamine Product Portfolio
  18. 7.3.5 Sandoz Recent Developments
  19. 7.4 Mylan
  20. 7.4.1 Mylan Company Information
  21. 7.4.2 Mylan Business Overview
  22. 7.4.3 Mylan Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Mylan Ketorolac Tromethamine Product Portfolio
  24. 7.4.5 Mylan Recent Developments
  25. 7.5 Pfizer
  26. 7.5.1 Pfizer Company Information
  27. 7.5.2 Pfizer Business Overview
  28. 7.5.3 Pfizer Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Pfizer Ketorolac Tromethamine Product Portfolio
  30. 7.5.5 Pfizer Recent Developments
  31. 7.6 Sagent Pharmaceuticals
  32. 7.6.1 Sagent Pharmaceuticals Company Information
  33. 7.6.2 Sagent Pharmaceuticals Business Overview
  34. 7.6.3 Sagent Pharmaceuticals Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Sagent Pharmaceuticals Ketorolac Tromethamine Product Portfolio
  36. 7.6.5 Sagent Pharmaceuticals Recent Developments
  37. 7.7 Omeros Corporation
  38. 7.7.1 Omeros Corporation Company Information
  39. 7.7.2 Omeros Corporation Business Overview
  40. 7.7.3 Omeros Corporation Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Omeros Corporation Ketorolac Tromethamine Product Portfolio
  42. 7.7.5 Omeros Corporation Recent Developments
  43. 7.8 Gland Pharma Limited
  44. 7.8.1 Gland Pharma Limited Company Information
  45. 7.8.2 Gland Pharma Limited Business Overview
  46. 7.8.3 Gland Pharma Limited Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Gland Pharma Limited Ketorolac Tromethamine Product Portfolio
  48. 7.8.5 Gland Pharma Limited Recent Developments
  49. 7.9 Egalet US Inc.
  50. 7.9.1 Egalet US Inc. Company Information
  51. 7.9.2 Egalet US Inc. Business Overview
  52. 7.9.3 Egalet US Inc. Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Egalet US Inc. Ketorolac Tromethamine Product Portfolio
  54. 7.9.5 Egalet US Inc. Recent Developments
  55. 7.10 Dr. Reddy’s Laboratories
  56. 7.10.1 Dr. Reddy’s Laboratories Company Information
  57. 7.10.2 Dr. Reddy’s Laboratories Business Overview
  58. 7.10.3 Dr. Reddy’s Laboratories Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Dr. Reddy’s Laboratories Ketorolac Tromethamine Product Portfolio
  60. 7.10.5 Dr. Reddy’s Laboratories Recent Developments
  61. 7.11 Aurobindo Pharma
  62. 7.11.1 Aurobindo Pharma Company Information
  63. 7.11.2 Aurobindo Pharma Business Overview
  64. 7.11.3 Aurobindo Pharma Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Aurobindo Pharma Ketorolac Tromethamine Product Portfolio
  66. 7.11.5 Aurobindo Pharma Recent Developments
  67. 7.12 Apotex
  68. 7.12.1 Apotex Company Information
  69. 7.12.2 Apotex Business Overview
  70. 7.12.3 Apotex Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Apotex Ketorolac Tromethamine Product Portfolio
  72. 7.12.5 Apotex Recent Developments
  73. 7.13 Amphastar Pharmaceuticals
  74. 7.13.1 Amphastar Pharmaceuticals Company Information
  75. 7.13.2 Amphastar Pharmaceuticals Business Overview
  76. 7.13.3 Amphastar Pharmaceuticals Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Amphastar Pharmaceuticals Ketorolac Tromethamine Product Portfolio
  78. 7.13.5 Amphastar Pharmaceuticals Recent Developments
  79. 7.14 Allergan
  80. 7.14.1 Allergan Company Information
  81. 7.14.2 Allergan Business Overview
  82. 7.14.3 Allergan Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Allergan Ketorolac Tromethamine Product Portfolio
  84. 7.14.5 Allergan Recent Developments
  85. 7.15 Akorn
  86. 7.15.1 Akorn Company Information
  87. 7.15.2 Akorn Business Overview
  88. 7.15.3 Akorn Ketorolac Tromethamine Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Akorn Ketorolac Tromethamine Product Portfolio
  90. 7.15.5 Akorn Recent Developments
8 North America
  1. 8.1 North America Ketorolac Tromethamine Market Size by Type
  2. 8.1.1 North America Ketorolac Tromethamine Revenue by Type (2021-2032)
  3. 8.1.2 North America Ketorolac Tromethamine Sales by Type (2021-2032)
  4. 8.1.3 North America Ketorolac Tromethamine Price by Type (2021-2032)
  5. 8.2 North America Ketorolac Tromethamine Market Size by Application
  6. 8.2.1 North America Ketorolac Tromethamine Revenue by Application (2021-2032)
  7. 8.2.2 North America Ketorolac Tromethamine Sales by Application (2021-2032)
  8. 8.2.3 North America Ketorolac Tromethamine Price by Application (2021-2032)
  9. 8.3 North America Ketorolac Tromethamine Market Size by Country
  10. 8.3.1 North America Ketorolac Tromethamine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Ketorolac Tromethamine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Ketorolac Tromethamine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Ketorolac Tromethamine Market Size by Type
  2. 9.1.1 Europe Ketorolac Tromethamine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Ketorolac Tromethamine Sales by Type (2021-2032)
  4. 9.1.3 Europe Ketorolac Tromethamine Price by Type (2021-2032)
  5. 9.2 Europe Ketorolac Tromethamine Market Size by Application
  6. 9.2.1 Europe Ketorolac Tromethamine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Ketorolac Tromethamine Sales by Application (2021-2032)
  8. 9.2.3 Europe Ketorolac Tromethamine Price by Application (2021-2032)
  9. 9.3 Europe Ketorolac Tromethamine Market Size by Country
  10. 9.3.1 Europe Ketorolac Tromethamine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Ketorolac Tromethamine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Ketorolac Tromethamine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Ketorolac Tromethamine Market Size by Type
  2. 10.1.1 China Ketorolac Tromethamine Revenue by Type (2021-2032)
  3. 10.1.2 China Ketorolac Tromethamine Sales by Type (2021-2032)
  4. 10.1.3 China Ketorolac Tromethamine Price by Type (2021-2032)
  5. 10.2 China Ketorolac Tromethamine Market Size by Application
  6. 10.2.1 China Ketorolac Tromethamine Revenue by Application (2021-2032)
  7. 10.2.2 China Ketorolac Tromethamine Sales by Application (2021-2032)
  8. 10.2.3 China Ketorolac Tromethamine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Ketorolac Tromethamine Market Size by Type
  2. 11.1.1 Asia Ketorolac Tromethamine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Ketorolac Tromethamine Sales by Type (2021-2032)
  4. 11.1.3 Asia Ketorolac Tromethamine Price by Type (2021-2032)
  5. 11.2 Asia Ketorolac Tromethamine Market Size by Application
  6. 11.2.1 Asia Ketorolac Tromethamine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Ketorolac Tromethamine Sales by Application (2021-2032)
  8. 11.2.3 Asia Ketorolac Tromethamine Price by Application (2021-2032)
  9. 11.3 Asia Ketorolac Tromethamine Market Size by Country
  10. 11.3.1 Asia Ketorolac Tromethamine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Ketorolac Tromethamine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Ketorolac Tromethamine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Ketorolac Tromethamine Market Size by Type
  2. 12.1.1 SAMEA Ketorolac Tromethamine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Ketorolac Tromethamine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Ketorolac Tromethamine Price by Type (2021-2032)
  5. 12.2 SAMEA Ketorolac Tromethamine Market Size by Application
  6. 12.2.1 SAMEA Ketorolac Tromethamine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Ketorolac Tromethamine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Ketorolac Tromethamine Price by Application (2021-2032)
  9. 12.3 SAMEA Ketorolac Tromethamine Market Size by Country
  10. 12.3.1 SAMEA Ketorolac Tromethamine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Ketorolac Tromethamine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Ketorolac Tromethamine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Ketorolac Tromethamine Value Chain Analysis
  2. 13.1.1 Ketorolac Tromethamine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Ketorolac Tromethamine Production Mode & Process
  6. 13.2 Ketorolac Tromethamine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Ketorolac Tromethamine Distributors
  9. 13.2.3 Ketorolac Tromethamine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst